Advances in CAR T-Cell Therapy for Leukemia, Lymphoma, and Myeloma: Where We Are and Where We Are Going

Download All
In this online program, experts discuss best practices and emerging strategies in CAR T-cell therapy for patients with leukemia, lymphoma, and myeloma. Watch the on-demand Webcast, download the slides from a dynamic CCO symposium in Orlando, and read expert commentaries to learn more about how to integrate CAR T-cells into your clinical practice.
person default
Stephen J. Schuster, MD
Program Director
Matthew J. Frigault, MD
James K. Kochenderfer, MD
Jae H. Park, MD

On-Demand Webcast

In this interactive, CME-certified Webcast, experts review the latest updates in CAR-T cell therapy and offer their insights on current best practices for patients with hematologic cancers.

person default Stephen J. Schuster, MD
Program Director
Matthew J. Frigault, MD James K. Kochenderfer, MD Jae H. Park, MD
Physicians: maximum of 2.25 AMA PRA Category 1 Credits Released: January 30, 2020 Expired: No longer available for credit
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
Celgene Corporation
Kite, A Gilead Company

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings